{
    "nctId": "NCT02102243",
    "officialTitle": "The Role of Aldosterone on Sympathetic Nerve Activity and Insulin Sensitivity",
    "inclusionCriteria": "1. Normotensive controls\n2. Stage I (140-159/90-99 mmHg) untreated subjects with essential hypertension\n3. Patients with PA and stage I (140-159/90-99 mmHg) hypertension\n* Must have minimum age of 18 Years\n* Must have maximum age of 75 Years",
    "exclusionCriteria": "1. Congestive heart failure or coronary artery disease\n2. Blood pressure averaging \\> 159/99 mmHg\n3. Serum creatinine \\> 1.5 mg/dL\n4. Diabetes mellitus or other systemic illness\n5. Left ventricular hypertrophy by echocardiography or ECG\n6. Pregnancy\n7. Hypersensitivity to spironolactone, chlorthalidone, amlodipine, human recombinant insulin or Definity\n8. Any history of substance abuse (other than tobacco)\n9. History of gouty arthritis\n10. Patients with right-to-left, bi-directional, or transient right-to-left cardiac shunts\n11. Hypersensitivity to perflutren, blood, blood products or albumin"
}